Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 3Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Precancerous Conditions 1Neoplasms, Second Primary 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Head and Neck Fibrosis 1Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Adenomatous Polyps 1

Interventions

Cisplatin 252Radiotherapy 176Cetuximab 144pembrolizumab 120Docetaxel 96Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Gefitinib 21Cyclophosphamide 21Surveys and Questionnaires 20Surgical Procedures, Operative 19Standard of Care 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15Low-Level Light Therapy 14Everolimus 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × alpha-Tocopherol × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡